As the Southern U.S. continues to navigate cases of New World screwworm, the Foundation for Food & Agriculture Research (FFAR) and the University of Notre Dame are investing $140,389 in a Rapid Outcomes from Agricultural Research (ROAR) grant to evaluate whether an existing drug can be repurposed to kill screwworm larvae.
The reemergence of New World screwworm is now threatening U.S. livestock production, wildlife and agricultural trade. Reports of reduced effectiveness of some commonly used treatments in South America, combined with the limited number of approved control options, underscore the need to evaluate new approaches. This urgently needed research could provide producers and veterinarians with an additional tool to protect livestock and strengthen U.S. preparedness.
Led by Dr. Lee Haines, associate research professor of biological sciences at the University of Notre Dame, and Dr. Álvaro Acosta-Serrano, professor of biological science at the University of Notre Dame, a team of researchers are evaluating whether nitisinone, a U.S. Food & Drug Administration (FDA)-approved drug with an established safety profile in humans, can effectively kill screwworm-related blowfly larvae. Research breakthroughs over the last five years have shown that nitisinone also kills several blood-feeding arthropods (including mosquitoes, ticks, kissing bugs, bed bugs, tsetse flies and stable flies) by blocking a key enzyme they need to digest blood, which is also found in screwworms.